Cargando…

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance

Multidrug resistance (MDR) of tumor cells to chemotherapeutic agents is the main reason for the failure of cancer chemotherapy. Overexpression of ABCB1 transporter that actively pumps various drugs out of the cells has been considered a major contributing factor for MDR. Over the past decade, many a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xiaofang, Teng, Qiu-Xu, Dong, Jin-Yun, Yang, Dong-Hua, Wang, Meifeng, Dessie, Wubliker, Qin, Jiang-Jiang, Lei, Zi-Ning, Wang, Jing-Quan, Qin, Zuodong, Chen, Zhe-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438908/ https://www.ncbi.nlm.nih.gov/pubmed/32903706 http://dx.doi.org/10.3389/fphar.2020.01208

Ejemplares similares

The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide
por: Teng, Qiu-Xu, et al.
Publicado: (2020)

Recent advances in peptide-based therapeutic strategies for breast cancer treatment
por: Li, Ling, et al.
Publicado: (2023)

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
por: Ji, Ning, et al.
Publicado: (2018)

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2022)

Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
por: Feng, Sen-Ling, et al.
Publicado: (2020)

Study on extraction and antibacterial activity of aucubin from Eucommia ulmoides seed-draff waste biomass
por: Liao, Yunhui, et al.
Publicado: (2022)

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter
por: Fu, Han, et al.
Publicado: (2022)

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study
por: Ji, Ning, et al.
Publicado: (2019)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

Involvement of P-gp on Reversing Multidrug Resistance Effects of 23-Hydroxybetulinic Acid on Chemotherapeutic Agents
por: Liu, Zhihao, et al.
Publicado: (2021)

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
por: Liao, Dan, et al.
Publicado: (2019)

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
por: Wu, Zhuo-Xun, et al.
Publicado: (2021)

A FRET-ICT Dual-Modulated Ratiometric Fluorescence Sensor for Monitoring and Bio-Imaging of Cellular Selenocysteine
por: Wang, Zongcheng, et al.
Publicado: (2020)

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
por: Bin Kanner, Yuval, et al.
Publicado: (2023)

Cloning and Transcriptional Activity Analysis of the Porcine Abcb1 Gene Promoter: Transcription Factor Sp1 Regulates the Expression of Porcine Abcb1
por: Guo, Tingting, et al.
Publicado: (2018)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
por: Zhang, Wei, et al.
Publicado: (2018)

Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro
por: Yan, Yan-Yan, et al.
Publicado: (2017)

BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
por: He, Dan, et al.
Publicado: (2013)

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
por: Gao, Hai-Ling, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2020)

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
por: Wang, Jingqiu, et al.
Publicado: (2020)

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2016)

ABCB1 Gene Is Associated With Clinical Response to SNRIs in a Local Chinese Han Population
por: Shan, Xiao-Xiao, et al.
Publicado: (2019)

Cleavage Stimulation Factor Subunit 2: Function Across Cancers and Potential Target for Chemotherapeutic Drugs
por: Feng, Linfei, et al.
Publicado: (2022)

Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells
por: Ji, Shengping, et al.
Publicado: (2021)

Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer
por: Lima, Thiago S., et al.
Publicado: (2022)

Combination Effects of Antimicrobial Peptides
por: Yu, Guozhi, et al.
Publicado: (2016)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
por: Yang, Yuqi, et al.
Publicado: (2021)

Influence of ABCB1 Gene Polymorphism on Rivaroxaban Blood Concentration and Hemorrhagic Events in Patients With Atrial Fibrillation
por: Wang, Yan, et al.
Publicado: (2021)

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
por: Ma, Wenzhe, et al.
Publicado: (2015)

Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells
por: Wang, Fang, et al.
Publicado: (2015)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance
por: Huang, Bao-Yuan, et al.
Publicado: (2017)

Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023)

Y(6), an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
por: Zhao, Rui-Qiang, et al.
Publicado: (2019)

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
por: Tavares, Letícia C., et al.
Publicado: (2018)

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor
por: Yang, Yuqi, et al.
Publicado: (2020)

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
por: Qin, Jiang-Jiang, et al.
Publicado: (2017)

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Feng, Weiguo, et al.
Publicado: (2020)

Snake Venom Cathelicidins as Natural Antimicrobial Peptides
por: de Barros, Elizângela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a8h3kqh2ci3fc4059iv4t4p3g0